284 related articles for article (PubMed ID: 15819807)
1. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
[TBL] [Abstract][Full Text] [Related]
2. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
3. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
4. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
Maluf DG; Edwards EB; Kauffman HM
Transplantation; 2006 Dec; 82(12):1653-7. PubMed ID: 17198254
[TBL] [Abstract][Full Text] [Related]
5. Live donor liver transplantation in high MELD score recipients.
Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
[TBL] [Abstract][Full Text] [Related]
6. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match.
Avolio AW; Agnes S; Gasbarrini A; Nure E; Siciliano M; Castagneto M
Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263
[TBL] [Abstract][Full Text] [Related]
8. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
Gastaca M
Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
10. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
[TBL] [Abstract][Full Text] [Related]
11. UNOS Liver Registry: ten year survivals.
Waki K
Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
[TBL] [Abstract][Full Text] [Related]
12. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.
Briceño J; Ciria R; de la Mata M; Rufián S; López-Cillero P
Transplantation; 2010 Sep; 90(5):530-9. PubMed ID: 20581766
[TBL] [Abstract][Full Text] [Related]
13. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
15. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of moderately steatotic donor liver in transplantation.
Gao F; Xu X; Ling Q; Wu J; Zhou L; Xie HY; Wang HP; Zheng SS
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):29-33. PubMed ID: 19208511
[TBL] [Abstract][Full Text] [Related]
17. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
[TBL] [Abstract][Full Text] [Related]
18. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
Feng X; Wei YG; Li FQ; Yuan D; Jiang H; Du ZG; Yin J; Li B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):801-4. PubMed ID: 19024318
[TBL] [Abstract][Full Text] [Related]
19. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
[TBL] [Abstract][Full Text] [Related]
20. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
